20:41 , Jan 18, 2019 |  BC Week In Review  |  Financial News

Acceleron, Stemline price upsized follow-ons

Acceleron Pharma Inc. (NASDAQ:XLRN) and Stemline Therapeutics Inc. (NASDAQ:STML) have each priced upsized follow-ons, as one company prepares for key regulatory submissions and the other conducts its first product launch. Acceleron said Jan. 16 that...
14:50 , Jan 16, 2019 |  BC Extra  |  Financial News

Acceleron, Stemline price upsized follow-ons

Acceleron Pharma Inc. (NASDAQ:XLRN) and Stemline Therapeutics Inc. (NASDAQ:STML) have each priced upsized follow-ons, as one company prepares for key regulatory submissions and the other conducts its first product launch. Acceleron said Wednesday that it...
19:42 , Jan 26, 2018 |  BC Week In Review  |  Financial News

Follow-on roundup: Ultragenyx, Adamas, Rocket

Rare disease company Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) raised $250 million on Jan. 23 through the sale of 4.4 million shares at $57 in a bumped-up follow-on underwritten by J.P. Morgan, BofA Merrill Lynch, Goldman Sachs...
22:56 , Jan 24, 2018 |  BC Extra  |  Financial News

Follow-on roundup

At least six companies priced follow-ons, raising more than $600 million total. Rare disease company Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) raised $250 million on Tuesday through the sale of 4.4 million shares at $57 in a...
21:37 , Jan 5, 2018 |  BC Week In Review  |  Financial News

ProLung proposes $8.6M IPO

Lung cancer diagnostic play ProLung Inc. (Salt Lake City, Utah) proposed to raise up to $8.6 million in an IPO on NASDAQ underwritten by Maxim Group and Aegis Capital, according to an SEC filing on...
21:09 , Jan 5, 2018 |  BC Week In Review  |  Financial News

Sun BioPharma withdraws follow-on

Cancer company Sun BioPharma Inc. (OTCQB:SNBPD) withdrew its follow-on on Dec. 28, 2017, citing market conditions. On Dec. 18, the company proposed to raise up to $11.5 million in the follow-on underwritten by Aegis Capital...
18:40 , Dec 22, 2017 |  BC Week In Review  |  Financial News

Sun BioPharma proposes $11.5M follow-on

On Dec. 18, cancer company Sun BioPharma Inc. (OTCQB:SNBPD) proposed to raise $11.5 million through the sale of 834,000 units in a follow-on underwritten by Aegis Capital and Lake Street Capital Markets. Each unit comprises...
19:36 , Oct 6, 2017 |  BC Week In Review  |  Financial News

Ritter raises $23M in follow-on

Ritter Pharmaceuticals Inc. (NASDAQ:RTTR) raised $23 million through the sale of 34.6 million class A units at $0.40 and 9,180 class B units at $1,000 in a follow-on underwritten by Aegis Capital. Each class A...
20:10 , Sep 22, 2017 |  BC Week In Review  |  Financial News

MediWound prices $22M follow-on

On Sept. 19, dermatology company MediWound Ltd. (NASDAQ:MDWD) raised $22 million through the sale of 4.4 million shares at $5 in a follow-on underwritten by Cowen, Wells Fargo, Oppenheimer, SunTrust Robinson Humphrey and Aegis Capital....
17:31 , Sep 15, 2017 |  BC Week In Review  |  Financial News

ADial proposes $16.1M IPO

On Sept. 6, alcohol abuse company ADial Pharmaceuticals LLC (Charlottesville, Va.) proposed to raise $16.1 million through the sale of 1.4 million shares in an IPO on NASDAQ underwritten by Aegis Capital Corp. ADial Pharmaceuticals...